Principal Financial Group
BCYC

Principal Financial Group’s Bicycle Therapeutics BCYC Stock Holding History

Principal Financial Group’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,174,625
Closed -$5.45M – 2173
2026
Q1 		$5.45M Buy
1,174,625
+26,353
+2% +$151K ﹤0.01% 1602
2025
Q4 		$8.13M Sell
1,148,272
-130
-0% -$958 ﹤0.01% 1426
2025
Q3 		$8.89M Buy
1,148,402
+451,135
+65% +$3.41M ﹤0.01% 1350
2025
Q2 		$4.85M Buy
697,267
+66,007
+10% +$526K ﹤0.01% 1587
2025
Q1 		$5.36M Buy
631,260
+224,790
+55% +$2.65M ﹤0.01% 1544
2024
Q4 		$5.69M Sell
406,470
-36,671
-8% -$786K ﹤0.01% 1555
2024
Q3 		$10M Buy
+443,141
New +$10.2M 0.01% 1274

Other funds holding BCYC

PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Principal Financial Group's BCYC Position: Q2 2026 in Review

Principal Financial Group sold out of Bicycle Therapeutics (BCYC) in Q2 2026, closing a stake of 1,174,625 shares — an estimated $5.45M sold.

Principal Financial Group first reported a position in BCYC in Q3 2024 and held it in 7 quarters. The position peaked at $10M in Q3 2024. 32 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Principal Financial Group reported no remaining Bicycle Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Principal Financial Group sold 1,174,625 Bicycle Therapeutics shares in Q2 2026, an estimated $5.45M.
  • Principal Financial Group first reported a position in Bicycle Therapeutics in Q3 2024 and held it in 7 quarters.
  • Principal Financial Group's Bicycle Therapeutics position peaked at $10M in Q3 2024.
  • 32 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.